The global artificial intelligence (AI) in life sciences market is witnessing transformative growth as AI technologies redefine research, drug discovery, and clinical development processes. Valued at USD 2,755.75 Million in 2025, the market is projected to reach USD 25,055.57 Million by 2035, growing at an impressive CAGR of 24.70% during the forecast period of 2026-2035. Rapid technological advancements, increasing adoption of AI-driven solutions, and rising investments by pharmaceutical and biotechnology companies are driving this surge.

Introduction: AI Revolutionizing Life Sciences

Artificial intelligence has emerged as a cornerstone of innovation in life sciences. By leveraging machine learning, deep learning, and natural language processing, AI enhances the efficiency and accuracy of drug discovery, clinical trials, and personalized medicine. It helps researchers analyze large datasets, identify patterns, and predict outcomes with unmatched precision, reducing time-to-market for new therapies and optimizing research costs.

AI applications in life sciences extend from computational biology and genomics to medical imaging and predictive analytics, providing organizations with actionable insights and enabling data-driven decision-making across the value chain.

Market Analysis: Drivers and Opportunities

1. Accelerated Drug Discovery

AI algorithms can rapidly analyze molecular structures, predict drug-target interactions, and identify potential candidates for clinical trials, significantly reducing development timelines.

2. Improved Clinical Trials

Machine learning models streamline patient recruitment, predict trial outcomes, and monitor safety signals, enhancing trial efficiency and reducing costs.

3. Integration of Omics and Real-World Data

AI systems enable integration and analysis of genomics, proteomics, and real-world patient data, aiding precision medicine and personalized therapies.

4. Increased R&D Investments

Pharmaceutical and biotech companies are heavily investing in AI platforms and partnerships to accelerate innovation and improve ROI in research and development.

5. Expansion of AI Infrastructure

Advancements in cloud computing, high-performance analytics, and AI platforms are driving scalability and accessibility of AI solutions in life sciences globally.

Download a free sample report along with a complete table of contents for review.

Leading Companies in the Market

Key players driving innovation in AI for life sciences include:

IBM Corporation

NuMedii Inc.

Atomwise Inc.

AiCure LLC

Nuance Communications Inc.

Databricks

IQVIA

SAS Institute Inc.

Sorcero

Indegene

These companies focus on AI-powered drug discovery, predictive analytics, and digital platforms to revolutionize healthcare and life sciences research.